Friday - 2021/07/23
HomeBanking & Finance

Banking & Finance

Vischer has acted as legal counsel to TargImmune Therapeutics, a private Swiss-based biotechnology firm, on the closing of its 2021 financing round, raising CHF 17.7 million. The Vischer legal team was led by Matthias Staehelin (pictured) with Francesca Pesenti and Nicolai Bleskie

Mey­er Bur­ger suc­cess­fully placed newly issued shares rais­ing gross pro­ceeds of CHF 80 mil­lion and EUR 145 mil­lion green guar­an­teed seni­or unse­cured con­vert­ible bonds. The bonds were issued by a Ger­man sub­si­di­ary and guar­an­teed by Mey­er Bur­ger Tech­no­logy. The con­vert­ible bonds are con­vert­ible into shares of Mey­er

Dec Group, a global provider of contained powder handling systems has acquired the Extract Technology business from U.S- based Wabash National Corporation, a company listed on the New York Stock Exchange. Extract Technology is a provider of containment and aseptic

Zurich based generics company, Fairmed Healthcare, which is majority owned by Strides Pharma Global, announced that it has raised €10 million in senior secured financing from Duke Royalty.   Urbach Law acted as transaction counsel for Fairmed Healthcare and Strides Pharma Global.

Raiffeisen Schweiz Genossenschaft, a Swiss systemically relevant bank, issued AT1 Bonds in the total amount of CHF 300 million.  With a base tranche of CHF 200 million on 31 March 2021 and a first reopening of CHF 100 million on 1 July 2021.  Homburger

Québec issued CHF 250 million Bonds. Deutsche Bank London Branch, acting through Deutsche Bank Zurich Branch acted as Lead Manager. The Bonds will be listed on the SIX Swiss Exchange.  Homburger advised Deutsche Bank Zurich Branch with a team led by partner René Bösch (capital markets, pictured) and

Nessun commento

Sorry, the comment form is closed at this time.


Hai dimenticato la Password?


Reset della password
Per favore inserisci la tua email. Riceverai una nuova password via email.